![Elizabeth Cormier-May](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elizabeth Cormier-May
Amministratore Delegato presso Mammogen, Inc.
Posizioni attive di Elizabeth Cormier-May
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mammogen, Inc.
![]() Mammogen, Inc. BiotechnologyHealth Technology Mammogen, Inc. is a female-led biotechnology company that focuses on improving the detection, diagnosis, and treatment of women's health-related diseases. Mammogen is based in Aliso Viejo, CA and was founded by Martin J. Keiser. The private company's proprietary gentrutm liquid biopsy platform, which leverages novel messenger RNA technology, is used in its flagship gentru-breasttm program to non-invasively detect and diagnose breast cancer. Mammogen's multi-gene expression signature for breast cancer detection has been extensively validated in blood and saliva, and has shown statistical significance towards providing measurable improvement upon current standards of care. The company's product pipeline consists of an array of non-invasive prognostics and diagnostics for additional diseases that affect some-, mostly-, or only-women. Elizabeth Cormier-May has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | 01/03/2021 | - |
Amministratore Delegato | 01/03/2021 | - | |
Dragonfly Data Factory LLC
![]() Dragonfly Data Factory LLC Internet Software/ServicesTechnology Services Dragonfly Data Factory LLC is an American company that operates an online platform for its clients to mine, manage, and monetize big data. The CEO of the private company is Elizabeth Cormier-May. | Amministratore Delegato | - | - |
Presidente | - | - | |
IV Bioholdings LLC | Corporate Officer/Principal | 01/01/2022 | - |
Persona Health, Inc. | Amministratore Delegato | - | - |
Storia della carriera di Elizabeth Cormier-May
Precedenti posizioni note di Elizabeth Cormier-May
Società | Posizione | Inizio | Fine |
---|---|---|---|
SAFE & GREEN HOLDINGS CORP. | Direttore/Membro del Consiglio | 06/01/2023 | 22/09/2023 |
Independent Dir/Board Member | 06/01/2023 | 22/09/2023 | |
Exosome Diagnostics, Inc.
![]() Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/05/2016 | 01/03/2019 |
Formazione di Elizabeth Cormier-May
Wheaton College (Massachusetts) | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SAFE & GREEN HOLDINGS CORP. | Producer Manufacturing |
Aziende private | 5 |
---|---|
Mammogen, Inc.
![]() Mammogen, Inc. BiotechnologyHealth Technology Mammogen, Inc. is a female-led biotechnology company that focuses on improving the detection, diagnosis, and treatment of women's health-related diseases. Mammogen is based in Aliso Viejo, CA and was founded by Martin J. Keiser. The private company's proprietary gentrutm liquid biopsy platform, which leverages novel messenger RNA technology, is used in its flagship gentru-breasttm program to non-invasively detect and diagnose breast cancer. Mammogen's multi-gene expression signature for breast cancer detection has been extensively validated in blood and saliva, and has shown statistical significance towards providing measurable improvement upon current standards of care. The company's product pipeline consists of an array of non-invasive prognostics and diagnostics for additional diseases that affect some-, mostly-, or only-women. Elizabeth Cormier-May has been the CEO of the company since 2021. | Health Technology |
Dragonfly Data Factory LLC
![]() Dragonfly Data Factory LLC Internet Software/ServicesTechnology Services Dragonfly Data Factory LLC is an American company that operates an online platform for its clients to mine, manage, and monetize big data. The CEO of the private company is Elizabeth Cormier-May. | Technology Services |
IV Bioholdings LLC | |
Exosome Diagnostics, Inc.
![]() Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
Persona Health, Inc. |